Bionime will participate in MEDICA 2026, taking place from November 16–19 in Düsseldorf, Germany. The company will showcase its latest innovation, the RIGHTEST iFree2 Continuous Glucose Monitoring (CGM) System, highlighting its commitment to advancing diabetes care worldwide.

Why healthcare partners are choosing iFree2 CGM:

1. Clinically Validated – Proven 8.4% MARD for top-tier reliability.
2. 15-Day Wear – Extended, uninterrupted baseline tracking.
3. Real-Time Data – Automated 1-minute streaming with zero manual scanning.
4. Calibration-Free – Factory calibrated with an ultra-compact design.

Backed by official EU MDR (CE) Certification, Bionime continues to expand its global presence and actively seeks international distribution partners and strategic collaborations to bring innovative glucose monitoring solutions to more people worldwide.

Event Details

• Event: MEDICA 2026
• Date: November 16–19, 2026
• Venue: Messe Düsseldorf, Germany
• Booth: Hall 01, Booth B65

We warmly invite healthcare professionals and potential partners to visit our booth and explore the future of glucose monitoring with Bionime.